$88.08
4.345.18%
At close: -
$88.20
0.120.14%
After Hours: 7:45 PM EDT
Comments
Loading...
Latest news for Novo Nordisk (NYSE:NVO) Stock
Novo Nordisk Stock (NYSE: NVO)
Categories: All
Friday, February 21, 2025
Wednesday, February 19, 2025
Tuesday, February 18, 2025
Friday, February 14, 2025
Thursday, February 13, 2025
Friday, February 07, 2025
- What the Options Market Tells Us About Novo Nordisk
- Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
- Novo Nordisk Announced Interim Results From P...
- Mark Cuban Calls Out Elon Musk's Growing Influence Under Trump: 'On A Mission To Make Himself...Above And Beyond The President Of The United States'
- Denmark Could Ban Or Push Ozempic, Wegovy And Shipping Prices Through The Roof If Trump Escalates Over Greenland
Thursday, February 06, 2025
Wednesday, February 05, 2025
- What To Expect When Eli Lilly Reports Q4 Earnings On Thursday?
- Novo Nordisk shares are trading higher after ...
- Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026
- Earnings Scheduled For February 5, 2025
- Novo Nordisk Forecasts 2025 Sales Growth Of 1...
- Novo Nordisk Q4 2024 GAAP EPS DKK 6.34 Beats ...
Tuesday, February 04, 2025
Monday, February 03, 2025
Thursday, January 30, 2025
Wednesday, January 29, 2025
Tuesday, January 28, 2025
Monday, January 27, 2025
Friday, January 24, 2025
- Stocks Stall, Gold Nears Record Highs As Dollar Faces Worst Week Since July 2023: What's Driving Markets Friday?
- Customers Bancorp, Twilio, Dana And Other Big Stocks Moving Higher On Friday
- Novo Nordisk shares are trading higher after ...
- Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
- Novo Nordisk Successfully Completes Phase 1b/...